For instance, Zheng et al. reported that FLT3 and TP53 mutations are common in Chinese ALL patients (31), and Zhang et al. reported high rates of FLT3 mutations in B-ALL (32). This evidence concerns the gene TP53 and acute lymphoblastic leukemia.